Circ Cardiovasc Qual Outcomes. 2022 Mar;15(3):e000105. doi: 10.1161/HCQ.0000000000000105. Epub 2022 Feb 22.
Low-value health care services that provide little or no benefit to patients are common, potentially harmful, and costly. Nearly half of the patients in the United States will receive at least 1 low-value test or procedure annually, creating risk of avoidable complications from subsequent cascades of care and excess costs to patients and society. Reducing low-value care is of particular importance to cardiovascular health given the high prevalence and costs of cardiovascular disease in the United States. This scientific statement describes the current scope and impact of low-value cardiovascular care; reviews existing literature on patient-, clinician-, health system-, payer-, and policy-level interventions to reduce low-value care; proposes solutions to achieve meaningful and equitable reductions in low-value care; and suggests areas for future research priorities.
低价值的医疗服务通常对患者几乎没有益处或没有益处,而且可能有害且昂贵。美国近一半的患者每年至少会接受 1 种低价值的检查或治疗,这可能导致后续治疗过程中出现可避免的并发症,以及给患者和社会带来额外的成本。鉴于心血管疾病在美国的高发病率和高成本,减少低价值的医疗服务对心血管健康尤为重要。本科学声明描述了当前低价值心血管护理的范围和影响;回顾了关于减少低价值护理的患者、临床医生、医疗系统、支付方和政策层面的干预措施的现有文献;提出了解决方案,以实现有意义和公平地减少低价值护理;并为未来的研究重点提出了建议。